Responding to allegations of scientific misconduct |
| |
Authors: | Jean-Philippe Breittmayer Martine Bungener Hugues De The Evelyne Eschwege Michel Fougereau Gilles Guedj Claude Kordon Olivier Philippe Maric-Catherine Postel-Vinay Laurence Schaffar-Esterle |
| |
Affiliation: | (1) INSERM U.343, Nice;(2) INSERM, U.502, Paris;(3) CNRS UPR 9051, Paris;(4) INSERM, Villejuif;(5) INSERM U.136, Marseille;(6) Service Juridique de l’INSERM, Paris;(7) INSERM U. 159, Paris;(8) INRA, Paris;(9) INSERM U. 344, Paris;(10) Service des Programmes, INSERM, 101 rue de Tolbiac, 75654 PARIS Cedex 13, FRANCE |
| |
Abstract: | Institutions in France are not yet well prepared to respond to allegations of scientific misconduct. Following a serious allegation in late 1997. INSERM,* the primary organization for medical and health-related research in France, began to reflect on this subject, aided by scientists and jurists. The conclusions have resulted in establishing a procedure to be followed in cases of alleged misconduct, and also in reinforcing the application of good laboratory practices within each laboratory. Guidelines for authorship practices and scientific assessment must also be considered. Even though each institution must remain responsible for responding to allegations of scientific misconduct within its doors, INSERM would like to see national, European, and international co-ordination about the methods of such response. Institut National de la Santé et de la Recherche Médicale (eng. French National Medical Research Institute) is known as INSERM. An earlier version of this paper was presented at a symposium, Scientific Misconduct: An International Perspective, organised by The Medical University of Warsaw, 16 November, 1998. |
| |
Keywords: | Scientific misconduct good laboratory practices research institution |
本文献已被 PubMed SpringerLink 等数据库收录! |
|